The decline in the price of shares of Sopharma during the trading session of Wednesday from 3.24% yesterday and the minimum recovery of only 0.24% led to a new leader among the largest public companies in Bulgaria.
Another pharmaceutical company – Tchaikapharma High Quality Medicines Inc. took the forefront place with a market value of BGN 359.9 million versus BGN 358 million for Sopharma.
Since Monday, 12th September, also the shares from the capital increase of Tchaikapharma High Quality Medicines Inc. will be introduced in trade.
We recall that the General meeting of the Shareholders decided BGN 7milion from last year’s profit amounting to 7.78 million to be used for capital increase.
Therefore each shareholder as at July 5th is getting another 0.141129 shares, and as a matter of fact – completely costless.
Starting from Monday, the company’s capital will be totaling BGN 56.6 million versus the current BGN 49.6 million.
For the first six months of 2016 Tchaikapharma High Quality Medicines Inc. reported a net profit of BGN 4.5 million against a positive financial result of BGN 3.9 million.
The company’s stocks were introduced for trading on the Bulgarian stock Exchange on May 21th, 2015. Only 17 ½ months later it is now the largest public company in the country.
____
The original article is available in Bulgarian at Profit.bg
http://profit.bg/news/Nova-naj-golyama-publichna-kompaniya-u-nas/nid-154250.html